UKALL 2003

Trial overview

Please copy and paste the URL below into a new window for more information on UKALL 2003:

http://www.ctsu.ox.ac.uk/

Then go to 'Projects', 'UKALL2003' 

Contact details

Principal Investigator

Prof Bowen

Tel 01132068481

Email david.bowen@leedsth.nhs.uk

Research Nurse

Alex Stichler

Tel 01132068577

Email alex.stichler@leedsth.nhs.uk



Other trials currently active for Acute Lymphoblastic Leukaemia

MRD Feasibility Study

Minimal Residual Disease monitoring in adult acute lymphoblastic leukaemia: a laboratory feasibility study.

UKALL 14

A randomized trial for adults with newly diagnosed acute lymphoblastic leukaemia.

For precursor-B lineage ALL, the main aim is to determine if the addition of Rituximab to standard induction chemotherapy results in improved EFS.

For T lineage ALL, the main aim is to determine if the addition of nelarabine following standard induction therapy improves outcomes.


Tags

acute lymphoblastic leukaemia all